How long does it take to become resistant to Platinib?
The resistance time of platinib is a complex issue that varies from person to person. It is affected by many factors, including the patient's condition, physical fitness, genetic mutation, and response to the drug.
According to clinical studies and patient feedback, resistance to platinib usually develops after taking 9 to 11 months. However, this is only a general time frame and the exact time will vary based on individual differences. Some patients may develop resistance to the drug after taking it for a longer period of time, while others may become resistant to the drug within a shorter period of time.

The patient's disease stability and physical fitness have an important impact on the resistance time of platinib. Patients with stable conditions and good physical fitness are often able to maintain the effectiveness of drugs for a longer period of time, while patients with recurring conditions and poor physical fitness may develop drug resistance more quickly.
The type and degree of RET gene mutation will also affect the efficacy and resistance time of platinib. Certain types of mutations may make patients more sensitive to drugs, thereby prolonging drug resistance, while other types of mutations may accelerate the development of drug resistance.
The patient's response to platinib is equally important as is its absorption. Patients who respond well and absorb well tend to achieve longer-lasting effects, while patients who respond poorly and absorb poorly may face drug resistance problems more quickly.
When a patient develops platinib resistance, doctors usually adjust the treatment plan based on the patient's specific condition. This may include switching to other targeted drugs, using multiple drugs in combination, or using other treatments (such as chemotherapy, radiotherapy, etc.) to control the disease. Therefore, patients should pay close attention to their physical condition during medication, communicate with their doctors in a timely manner and make adjustments according to their instructions.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)